Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 18

    1.

    The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.

    Yu C, Zhang Z, Liao W, Zhao X, Liu L, Wu Y, Liu Z, Li Y, Zhong Y, Chen K, Li J, Zhou F, Song L.

    Carcinogenesis. 2012 Mar;33(3):678-86. Epub 2012 Jan 4.

    PMID:
    22223847
    [PubMed - indexed for MEDLINE]
    2.

    The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

    Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, Hall J, Landi S, Bishop DT, Kiltie AE.

    Carcinogenesis. 2012 Mar;33(3):581-6. Epub 2011 Dec 12.

    PMID:
    22166496
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.

    Bhattacharya A, Li Y, Geng F, Munday R, Zhang Y.

    Carcinogenesis. 2012 Feb;33(2):394-8. Epub 2011 Nov 30.

    PMID:
    22131350
    [PubMed - in process]
    4.

    MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.

    Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL, Dahiya R.

    Carcinogenesis. 2012 Jan;33(1):41-8. Epub 2011 Nov 1.

    PMID:
    22049531
    [PubMed - indexed for MEDLINE]
    5.

    Thioredoxin-interacting protein suppresses bladder carcinogenesis.

    Nishizawa K, Nishiyama H, Matsui Y, Kobayashi T, Saito R, Kotani H, Masutani H, Oishi S, Toda Y, Fujii N, Yodoi J, Ogawa O.

    Carcinogenesis. 2011 Oct;32(10):1459-66. Epub 2011 Jul 18.

    PMID:
    21771725
    [PubMed - indexed for MEDLINE]
    6.

    Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations.

    Nishiyama N, Arai E, Nagashio R, Fujimoto H, Hosoda F, Shibata T, Tsukamoto T, Yokoi S, Imoto I, Inazawa J, Kanai Y.

    Carcinogenesis. 2011 Apr;32(4):462-9. Epub 2010 Dec 22.

    PMID:
    21177765
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.

    Wang M, Chu H, Yan F, Qin C, Li P, Yuan L, Yin C, Xu J, Zhang Z.

    Carcinogenesis. 2011 Jun;32(6):872-5. Epub 2011 Mar 31.

    PMID:
    21459758
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Urinary pH, cigarette smoking and bladder cancer risk.

    Alguacil J, Kogevinas M, Silverman DT, Malats N, Real FX, García-Closas M, Tardón A, Rivas M, Torà M, García-Closas R, Serra C, Carrato A, Pfeiffer RM, Fortuny J, Samanic C, Rothman N.

    Carcinogenesis. 2011 Jun;32(6):843-7. Epub 2011 Mar 14.

    PMID:
    21402590
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    In vitro functional effects of XPC gene rare variants from bladder cancer patients.

    Qiao B, Ansari AH, Scott GB, Sak SC, Chambers PA, Elliott F, Teo MT, Bentley J, Churchman M, Hall J, Taylor CF, Bishop TD, Knowles MA, Kiltie AE.

    Carcinogenesis. 2011 Apr;32(4):516-21. Epub 2011 Jan 27.

    PMID:
    21273643
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.

    Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, Cortessis VK, Pike MC, Xiang YB, Gao YT, Yuan JM, Van Den Berg DJ.

    Carcinogenesis. 2011 Feb;32(2):197-202. Epub 2010 Nov 15.

    PMID:
    21081471
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues.

    Ding Y, Paonessa JD, Randall KL, Argoti D, Chen L, Vouros P, Zhang Y.

    Carcinogenesis. 2010 Nov;31(11):1999-2003. Epub 2010 Sep 1.

    PMID:
    20810543
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

    Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N.

    Carcinogenesis. 2011 Feb;32(2):182-9. Epub 2010 Oct 29.

    PMID:
    21037224
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Allyl isothiocyanate-rich mustard seed powder inhibits bladder cancer growth and muscle invasion.

    Bhattacharya A, Li Y, Wade KL, Paonessa JD, Fahey JW, Zhang Y.

    Carcinogenesis. 2010 Dec;31(12):2105-10. Epub 2010 Oct 1.

    PMID:
    20889681
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer.

    Wilhelm-Benartzi CS, Koestler DC, Houseman EA, Christensen BC, Wiencke JK, Schned AR, Karagas MR, Kelsey KT, Marsit CJ.

    Carcinogenesis. 2010 Nov;31(11):1972-6. Epub 2010 Aug 28.

    PMID:
    20802236
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Hypertension, diuretics and antihypertensives in relation to bladder cancer.

    Jiang X, Castelao JE, Yuan JM, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M.

    Carcinogenesis. 2010 Nov;31(11):1964-71. Epub 2010 Aug 23.

    PMID:
    20732908
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.

    Liu HS, Hsu PY, Lai MD, Chang HY, Ho CL, Cheng HL, Chen HT, Lin YJ, Wu TJ, Tzai TS, Chow NH.

    Carcinogenesis. 2010 Aug;31(8):1456-64. Epub 2010 May 24.

    PMID:
    20498137
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients.

    Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, Wu X.

    Carcinogenesis. 2010 Aug;31(8):1387-91. Epub 2010 Jun 7.

    PMID:
    20530239
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population.

    Wang S, Tang J, Wang M, Yuan L, Zhang Z.

    Carcinogenesis. 2010 Apr;31(4):621-4. Epub 2010 Jan 18.

    PMID:
    20083643
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk